intoxication is the clinical hallmark of X-linked ornithine transcsrbamylase (OTC) deficiency. Hemizygous affected males have less residual OTC activity and more serious clinical consequences than do heterozygous females. We now describe some immunochemical features of mutant OTC in affected males and females. A monospecific antiserum againat purified bovine hepatic OTC has been prepared in rabbits. Imnunotitration shows that the antiserum can completely precipitate human OTC and that a given amount complexes bovine and human activity comparably. We have employed this antiserum in an Ouchterlony double diffusion system and in a classical immune precipitation inhibition assay. This latter method consistently detects <1% of control cross-reacting material (CRM).
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Livers from four affected males (OTC activities c0.1-10% of control) and two females (8 and 20%) have been studied with these techniques. Whereas only the female with 20% of residual activity shows a precipitin line by the Ouchterlony technique, both females and the two males with the greatest residual activities (10 and 0.3%) have detectable CRM by immune precipitation inhibition. In these four cases the percent of residual CRM approximates that of enzymatic activity. In the two males with enzymatic activity <0.1%, no CRM has been found. The observed agreement between residual enzymatic activity and CRM may reflect structural gene mutations which alter the rate of degradation and/or synthesis of OTC protein. A Mexican-American female, G.M., was seen at 4 years of age with spasticity, hypertonicity, loss of ability to walk, decreased weight and length, severe microcephaly, marked EEG abnormalities without seizures, and normal blood ammonia. Blood arginine levels ranged from 390 to 1074 pmolll (normal 61 to 173).
Increased arginine and argininosuccinic acid were present in the urine. Arginase activity in red blood cells was 24 nmol/hr/mg hemoglobin with a mean of 1784 and a range of 825 to 2446 in 10 control samples. Decreased activity consistent with a heterozygote state was present in the mother and in 5 of 6 siblings. Arginase activity in a percutaneous liver biopsy was 1580 nmollhrlmg protein with a range of 89.000 to 158.000 in 4 controls. Arginase was ~1 0 0 nmollhrlmg protein in skin clippings with a range of 18,000 to 103,000 in 7 controls. Arginase activity was measured as ornithine production in extracts of cultured skin fibroblasts and found to be 22.5 nmol lhrlmg protein in the propositus with a control range of 14.9 to 43.8. We are evaluating whether control fibroblast arginase activity is lower when serum of the propositus is substituted for fetal calf serum in the growth medium. The low level of fibroblast arginase was also measurable as production of [ 1 4~] urea from [lb~-~uanido] arginine. Therapy was attempted by oral administration of up to 500 mglkgld of L-lysine and subsequently by infusion of 8 mllkg packed red blood cells (post-transfusion red cell arginase, 695 nmollhrlmg hemoglobin), but neither attempt had convincing effects on serum arginine or clinical parameters. A child with phenylketonuria diagnosed early developed severe hypotonia with minimal signs of spasticity and retardation in all developmental patterns despite adequate dietary management. At 4 years of age, a liver biopsy was performed and the components of the phenylalanine hydroxylase system were measured in vitro. Normal levels of phenylalanine hydroxylase, dihydropteridine reductase and dihydrofolate reductase were found. However, there was only 5% of the normal level of active phenylalanine hyrlroxylase cofactor. This cofactor deficiency was also demonstrable in plasma and urine. Since the phenylalanine hydroxylase cofactor (tetrahydrobiopterin) is probably also necessary for the hydroxylation of tyrosine and tryptophan, the rate limiting steps in the biosynthesis of dopamine and norepinephrine and serotonin. this child may be suffering from a lack of these neurotransmitters.
The child's phenylalanine hydroxylsse activity has also been measured with a new in vivo method. In this procedure, hydroxylase activity is assayed by following the rate of formation of tritiated water from ring tritium labelled phenylslanine. Phenylalanine hydroxylase activity 1-5% of normal was detected & I vivo confirming the incomplete block in the conversion of phenyl--alanine to tyrosine predicted by the in vitro assays on the liver biopsy.
THREE GENERATIONS OF HEREDITARY COPROPORPHYRIA (HC).
533 Ursula Muller-Eberhard. Ann Smith, Irene Bossenmaier, and Ruth Cardinal, Scripps Clinic and Research Foundation. Department of Biochemirtrv. La Jolla. Ca. 92037 and ~niverkity'of Minnesota, ~innea~oiis. Minn. 55407.
Hepatic porphyrias, disorders of heme synthesis, are rarely diagnosed in childhood. Two of three sons. ages 15 and 17 years. of a woman with longstanding neuromuscular disabilities eventually recognized to be associated with high urinary and fecal coproporphyrin (copro-P) exhibited similar biochemical findings. One son. W, shows the typical porphyrin excretion pattern, whereas WT has only coprouorphyrinuria. The mother took oral contraceptives over 10 years. How hormonal, nutritional and pharmacological factors contribute to the onset and clinical severity of the enzymatic defects in the porphyrias is not known. HC is rarely recorded (% 30 reported cases); to our knowledge the youngest was 10 years old. Thus, the incidence of latent carriers at risk is unknown. The relationship between the two a-glucosidases is of interest since the lysosomal and microsomal 0-glucuronidsses are products of the aame structural gene (Ovens, &. al., Arch. Biochem. Biophys. &6:258. 1975 ) while the lysosomal. Golgi and cytosolic a-manosidases appear to be genetically distinct (Tulsiani, &.d. Fed. Proc. 15:1727 , 1976 . The acid (lysosomal) a-glucosidase from human liver has been purified 2400-fold and its carbohydrate composition has been determined. The Con A binding of the acid a-glucosidase is prevented by D-mnnose or a-methy1-Dglucoside. At half saturation 12.5 moles of Con A are bound per mole of enzyme. The binding is demonstrable both with the purified enzyme and crude homogenstes. The neutral (soluble) a-glucosidase has been specifically assayed in homogenstes. In contrast to the acid glucosidase, Con A does not bind the neutral glucosidase which suggests that its carbohydrate moiety may differ from that of the acid glucosidase, if the neutral glucosidase is in fact a glycoprotein. Further, antiserum to the acid a-glucosidase inhibits its activity but in contrast has no effect on the activity of the neutral a-glucosidase. We are isolating the neutral a-glucosidase to further investigate the relationship between the two a-glucosidases.
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